Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 47 articles: HTML format

Single Articles

October 2025
1. WANG TW, Luo WT, Tu YK, Chou YB, et al
   Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
   Am J Ophthalmol. 2025 Oct 4:S0002-9394(25)00528.
   PubMed     Abstract available
   
   
   September 2025
2. FAN Y, Li L, Wu X, Yan Y, et al
   Longitudinal neural and microvascular changes in type 2 diabetic patients without retinopathy: a 2-year prospective cohort study.
   Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00503.
   PubMed     Abstract available
   
   
   July 2025
3. PRASAD M, Agron E, Vitale S, Arunachalam T, et al
   Diabetic retinopathy incidence, progression, and health-related quality of life from the ACCORD trial.
   Am J Ophthalmol. 2025 Jul 23:S0002-9394(25)00371.
   PubMed     Abstract available
   
   
   June 2025
4. NWANYANWU K, Andoh J, Chen E, Xu Y, et al
   Social Determinants Associated with Diabetic Retinopathy Awareness: National Health and Nutrition Examination Survey (2005-2008).
   Am J Ophthalmol. 2025 Jun 21:S0002-9394(25)00330.
   PubMed     Abstract available
   
   
   May 2025
5. PARK KS, Kim JT, Lee MW
   Macular Microvasculature Asymmetry Analysis for Evaluating Open-Angle Glaucoma in Diabetic Retinopathy Patients Treated with Pan-Retinal Photocoagulation.
   Am J Ophthalmol. 2025 May 23:S0002-9394(25)00248.
   PubMed     Abstract available
   
   
   
6. LAKHANI M, Kwan AT, Mihalache A, Popovic MM, et al
   Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
   Am J Ophthalmol. 2025 May 16:S0002-9394(25)00239.
   PubMed     Abstract available
   
   
   
7. HUSSAIN ZS, Shakarchi AF, Chauhan MZ, Jester DA, et al
   Is There a Safe Glycemic Threshold for Cataract Surgery?
   Am J Ophthalmol. 2025 May 3:S0002-9394(25)00221.
   PubMed     Abstract available
   
   
   March 2025
8. LIANG F, Tao S, Zhang Y, Liu S, et al
   Correlation between length of interdigitation zone with severity and progression of diabetic retinopathy.
   Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00152.
   PubMed     Abstract available
   
   
   
9. WANG Z, Yu Y, Ye Y, Wang L, et al
   Associations between Ambient Air Pollution and Five Common Vision-threatening Ocular Diseases in Middle-aged and Older Adults: A Large Prospective Cohort Study.
   Am J Ophthalmol. 2025 Mar 6:S0002-9394(25)00121.
   PubMed     Abstract available
   
   
   February 2025
10. LI M, He J, VanderBeek BL, Ying GS, et al
    Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular Edema.
    Am J Ophthalmol. 2025 Feb 26:S0002-9394(25)00095.
    PubMed     Abstract available
    
    
    
11. JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al
    Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex Virus.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096.
    PubMed     Abstract available
    
    
    
12. ABBASS NJ, Nahlawi R, Shaia JK, Allan KC, et al
    The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00094.
    PubMed     Abstract available
    
    
    
13. KHAN Z, Gaidhane AM, Singh M, Ganesan S, et al
    Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00081.
    PubMed     Abstract available
    
    
    
14. MAGRATH G, Luvisi J, Russakoff D, Oakley J, et al
    Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00073.
    PubMed     Abstract available
    
    
    
15. ANGUITA R, Desideri LF, Sivaprasad S, Wickham L, et al
    Reply to "Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2025 Feb 6:S0002-9394(25)00050.
    PubMed    
    
    
    
16. UZUN S, Blair MP
    Comment on: Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2025 Feb 5:S0002-9394(25)00049.
    PubMed    
    
    
    January 2025
17. TAKKAR B, Ketkar MR, Narula R, Tyagi M, et al
    A pilot randomized controlled trial evaluating haemostasis with fibrin glue during surgery for proliferative diabetic retinopathy.
    Am J Ophthalmol. 2025 Jan 28:S0002-9394(25)00040.
    PubMed     Abstract available
    
    
    December 2024
18. HUANG RS, Balas M, Jhaveri A, Popovic MM, et al
    Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis.
    Am J Ophthalmol. 2024 Dec 31:S0002-9394(24)00590.
    PubMed     Abstract available
    
    
    
19. AMARAL DC, Guedes J, Cruz MRB, Cheidde L, et al
    GLP-1 RECEPTOR AGONISTS USE AND INCIDENCE OF GLAUCOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS: GLP-1 receptor agonists use and incidence of glaucoma.
    Am J Ophthalmol. 2024 Dec 26:S0002-9394(24)00589.
    PubMed     Abstract available
    
    
    
20. ANGUITA R, Desideri LF, Sivaprasad S, Wickam L, et al
    Reply to Comment on "Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00573.
    PubMed    
    
    
    
21. NISHIDA K, Maeno T, Nishida K
    Comment on, Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Dec 17:S0002-9394(24)00572.
    PubMed    
    
    
    November 2024
22. MOU K, Zhang M
    Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00546.
    PubMed    
    
    
    
23. LIU K, Li T, Zhong P, Zhu Z, et al
    Reply to Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00547.
    PubMed    
    
    
    
24. ZAMAN M, Zajner C, Xie J, Patil NS, et al
    Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis.
    Am J Ophthalmol. 2024 Nov 16:S0002-9394(24)00524.
    PubMed     Abstract available
    
    
    
25. ENG K, Zebardast N, Boland MV, Lo JE, et al
    Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes.
    Am J Ophthalmol. 2024 Nov 6:S0002-9394(24)00506.
    PubMed     Abstract available
    
    
    October 2024
26. ANGUITA R, Ferro Desideri L, Schwember P, Shah N, et al
    Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 27:S0002-9394(24)00488.
    PubMed     Abstract available
    
    
    
27. DING X, Romano F, Garg I, Gan J, et al
    Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Non-Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 25:S0002-9394(24)00485.
    PubMed     Abstract available
    
    
    September 2024
28. KIM A, Ding X, Miller JB
    Ultra-widefield Swept-Source OCT Angiography vs. Ultra-widefield Fluorescein Angiography in Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Sep 17:S0002-9394(24)00419.
    PubMed    
    
    
    
29. TSAI WS, Thottarath S, Gurudas S, Pearce E, et al
    A Comparison of Optical Coherence Tomography Angiography Metrics and Artifacts on Scans of Different Sizes in Diabetic Macular Ischemia: The effect of different size scans on DMI evaluation.
    Am J Ophthalmol. 2024 Sep 13:S0002-9394(24)00433.
    PubMed     Abstract available
    
    
    
30. LUM F
    Comment on Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Study.
    Am J Ophthalmol. 2024 Sep 6:S0002-9394(24)00406.
    PubMed    
    
    
    
31. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Reply to comment on: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Sep 4:S0002-9394(24)00407.
    PubMed    
    
    
    
32. LIU K, Li T, Zhong P, Zhu Z, et al
    Longitudinal changes in retina and choroid across novel subtypes of diabetes mellitus: Subtypes of diabetes and retinal neurovascular changes.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00405.
    PubMed     Abstract available
    
    
    
33. HALLAJ S, Halfpenny W, Chuter BG, Weinreb RN, et al
    Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00392.
    PubMed     Abstract available
    
    
    August 2024
34. LEE MY, Han K, Min KH, Yu DS, et al
    Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
    Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395.
    PubMed     Abstract available
    
    
    
35. LEE SH, Tseng BY, Wu MC, Wang JH, et al
    Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2024 Aug 21:S0002-9394(24)00379.
    PubMed     Abstract available
    
    
    July 2024
36. RAHMATI M, Smith L, Boyer L, Fond G, et al
    Factors affecting global adherence for the uptake of diabetic retinopathy screening: A systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 31:S0002-9394(24)00335.
    PubMed     Abstract available
    
    
    
37. RAHIMY E, Koo EB, Wai KM, Ludwig CA, et al
    Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications.
    Am J Ophthalmol. 2024 Jul 30:S0002-9394(24)00323.
    PubMed     Abstract available
    
    
    
38. BANTOUNOU MA, Nahar TAK, Plascevic J, Kumar N, et al
    Drug exposure as a predictor in diabetic retinopathy risk prediction models; a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 19:S0002-9394(24)00313.
    PubMed     Abstract available
    
    
    June 2024
39. ARRUDA MP, Lima RV, Hira S, Moreira JLML, et al
    A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-retinal Photocoagulation.
    Am J Ophthalmol. 2024 Jun 26:S0002-9394(24)00264.
    PubMed     Abstract available
    
    
    May 2024
40. LI G, Sommi A, Klawe J, Ahmad S, et al
    Demographic and Systemic Risk Factors for Persistent Corneal Edema Following Cataract Surgery in Patients With and Without Diabetes.
    Am J Ophthalmol. 2024 May 25:S0002-9394(24)00228.
    PubMed     Abstract available
    
    
    
41. LIU X, Chang Y, Li Y, Liu Y, et al
    Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008.
    Am J Ophthalmol. 2024 May 16:S0002-9394(24)00223.
    PubMed     Abstract available
    
    
    
42. YILMAZ YC, Hayat SC, Ipek SC
    Corrigendum to Yilmaz YC, Hayat SC, Ipek SC. 'Analysis of Corneal and Lens Densitometry Changes in Patients With Type 1 Diabetes Mellitus' Am J Ophthalmol. 2023 Oct;254:23-30.
    Am J Ophthalmol. 2024 May 10:S0002-9394(24)00147.
    PubMed    
    
    
    
43. VOICHANSKI S, Bousquet E, Abraham N, Santina A, et al
    En Face Optical Coherence Tomography Illustrates the Trizonal Distribution of Drusen and Subretinal Drusenoid Deposits in the Macula.
    Am J Ophthalmol. 2024;261:187-198.
    PubMed     Abstract available
    
    
    April 2024
44. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Apr 16:S0002-9394(24)00150.
    PubMed     Abstract available
    
    
    March 2024
45. JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
    Diagnostic accuracy of artificial intelligence based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
    PubMed     Abstract available
    
    
    February 2024
46. DAI Y, Zheng D, Zhao J, Wang K, et al
    Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study.
    Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
    PubMed     Abstract available
    
    
    November 2023
47. DANZINGER V, Schartmuller D, Lisy M, Schranz M, et al
    Intraindividual Comparison Of An Enhanced Monofocal And An Aspheric Monofocal Intraocular Lens Of The Same Platform.
    Am J Ophthalmol. 2023 Nov 7:S0002-9394(23)00463.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.